PROPERTIES OF PLASMINOGEN ACTIVATORS FORMED BY NEOPLASTIC HUMAN CELL CULTURES
Open Access
- 1 May 1974
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 139 (5) , 1317-1328
- https://doi.org/10.1084/jem.139.5.1317
Abstract
A series of human cell lines has been examined for fibrinolysis in culture. The sera that are activating for fibrinolysis by human cells are mouse, monkey, human, horse, and bovine. Individual human sera show considerable variation in the ability to activate fibrinolysis. In common with other neoplastic or transformed mammalian and avian cell cultures, human cell lines of neoplastic origin produce substantial amounts of plasminogen activator. Several cultures of nonmalignant origin also produce plasminogen activator, whereas cultures obtained from trypsinized human embryos, or from human embryonic skin do not. The human melanoma plasminogen activators are of two kinds: a major component with a mol wt of 50,000, and a minor species with a mol wt of approximately 60,000. Both are DFP sensitive, serine proteases.Keywords
This publication has 10 references indexed in Scilit:
- Increased Plasminogen Activator (Urokinase) in Tissue Culture After Fibrin DepositionJournal of Clinical Investigation, 1973
- AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSESThe Journal of Experimental Medicine, 1973
- AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSESThe Journal of Experimental Medicine, 1973
- Selective lysis of cells transformed by Rous sarcoma virusVirology, 1971
- The Clinical Challenge of Disseminated Intravascular CoagulationNew England Journal of Medicine, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Plasminogen activator activity in cultures from human tissues. An immunological and histochemical studyJournal of Clinical Investigation, 1969
- ORIGIN OF FIBRINOLYTIC ACTIVITY IN CULTURES OF HUMAN KIDNEY1967
- Tissue activators of plasminogen.1966
- Prostatic fibrinolysinThe American Journal of Medicine, 1953